Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Alumna Parinda Wattanasri (cohort 2019-2020) was interviewed by Thailand Today on vaccine passports. and how they may become a sustainable plan to reopening Thailand.

Parinda still shot from the interview: Vaccine Passports: A Sustainable Plan to Reopening the Country
Alumna Parinda Wattanasri (cohort 2019-2020) being interviewed on Thailand Today

Listen to Parinda and how she draws her expertise on immunisation policy to give this amazing interview at Thailand Today.

Parinda started by explaining what a vaccine passport or certificate is, and how it helps health organisations assess the vaccination status of an individual. 

She then went to clarify that although vaccine passports nay be ready, they can only be used when the country reopens. 

The idea is to use a similar certificate to the yellow vaccine but more robust, as paper and digital versions will be made available.

Parinda then clarifies who is eligible to apply for this passport and mechanisms to apply and obtain this passport.

Alumna Parinda Wattanasri (cohort 2019-2020) is the Assistant director of the Institute of Preventive Medicine , Department of Diseases Control, Ministry of Public Health. She went on Thailand Today to talk about the vaccination passport project in Thailand



Similar stories

Congratulations 2021/22 MSc IHTM

The 2021/22 IHTM cohort gathered at Worcester College to celebrate the culmination of their MSc.

Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools

Simon Mendelsohn (cohort 2015-16) co-authored this paper investigating airborne MTB genomic DNA in classrooms as there is evidence of high tuberculosis disease burden among South African adolescents.

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Sandra Adele (cohort 2019-2020) co-authored this paper assessing the benefits of interval extension between BNT162b2 mRNA vaccine doses.

Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol

Simon Mendelsohn (cohort 2015-16) co-authored this systematic review protocol on the current triage and predictive tools and how host tuberculosis transcriptomic biomarkers may be more effective for a correct diagnosis.

Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis

Simon Mendelsohn (cohort 2015-16) co-authored this article.

Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021

Simon Mendelsohn (cohort 2015-16) co-authored this article on the Global Forum on Tuberculosis (TB) Vaccines and how this year's event focussed on opportunities and challenges for TB vaccine R&D during a pandemic.